Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Volume: 379, Issue: 5, Pages: 417 - 427
Published: Jun 3, 2018
Abstract
Background Cytoreductive nephrectomy has been the standard of care in metastatic renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies. However, the efficacy of targeted therapies has challenged this standard. We assessed the role of nephrectomy in patients with metastatic renal-cell carcinoma who were receiving targeted therapies. Methods In this phase 3 trial, we randomly assigned, in a 1:1 ratio,...
Paper Details
Title
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
Published Date
Jun 3, 2018
Volume
379
Issue
5
Pages
417 - 427
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.